Sample characteristics
Characteristics | Mean (SD) |
---|---|
Age, mean (SD) (n = 713) | 49 (12.7) range: 21–85 |
Length of time since MS onset, mean (SD) (n = 713) | 18 (12) range: 0–59 |
Gender, n (%) (n = 712) | |
Female | 597 (84%) |
Male | 100 (14%) |
Transgender, non-binary, gender non-conforming, or other | 15 (2%) |
MS subtype, n (%) (n = 712) | |
Relapsing remitting MS (RRMS) | 559 (78%) |
Secondary progressive MS (SPMS) | 87 (12%) |
Primary progressive MS (PPMS) | 35 (5%) |
Progressive Relapsing MS (PRMS) | 9 (1%) |
Unsure | 23 (3%) |
DMT, n (%) (n = 709) | |
None | 129 (18%) |
First line | 272 (38%) |
Second line | 308 (43%) |
Count of medication classes that can impact pain, mean (SD) (n = 705) | 1.63 (1.29) range: 0–5 |
Race/ethnicity, n (%) (n = 471) | |
White | 415 (88%) |
Bi-racial or mixed | 24 (5%) |
Black | 23 (5%) |
Asian | 4 (< 1%) |
Latinx | 2 (< 1%) |
American Indian or Alaska Native | 2 (< 1%) |
Native Hawaiian or Pacific Islander | 1 (< 1%) |
Smoking status, n (%) (n = 709) | |
Never smoker | 465 (66%) |
Former smoker | 198 (28%) |
Current or social smoker | 46 (6%) |
Education, n (%) (n = 713) | |
High school equivalency or below | 36 (5%) |
Associate degree or some college | 167 (23%) |
Bachelor’s degree | 259 (36%) |
Master’s degree or above | 251 (35%) |
Stressors, mean (SD) (n = 713) | |
Childhood count | 2.6 (1.96) |
Childhood severity | 9.8 (8.8) |
Adult count | 23.6 (14) |
Adult severity | 55.3 (30.8) |
Outcome variables (n = 713) | |
Fatigue, median (IQR), mean (SD) | 58 (52–63), 57 (9) |
Pain interference, median (IQR), mean (SD) | 54 (41–62), 53 (10.5) |
Psychiatric morbidity count, mean (SD) | 2.2 (1.7) range: 0–6 |